Trial Profile
Study of talabostat in advanced melanoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2007
Price :
$35
*
At a glance
- Drugs Talabostat (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 07 Jun 2007 Status changed from in progress to completed.
- 30 Sep 2005 New trial record.